Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Cystic Fibrosis Foundation Therapeutic Development Center Award
Billings, J. L. (PI) & Goldfarb, S. (CoI)
7/1/24 → 6/30/25
Project: Research project
-
University of Minnesota Clinical and Translational Science Institute (UMN CTSI)
Blazar, B. R. (PI), Beebe, T. J. (CoI), Bellin, M. D. (CoI), Berge, J. M. (CoI), Billings, J. L. (CoI), Bischof, J. C. (CoI), Brearley, A. M. (CoI), Call, K. T. (CoI), Fu, S. S. (CoI), Fulkerson, J. (CoI), Guan, W. (CoI), Hardeman, R. R. (CoI), Haynes, D. A. (CoI), Henning-Smith, C. E. (CoI), Johnson, S. (CoI), Jones-Webb, R. J. (CoI), Kozhimannil, K. B. (CoI), Langworthy, B. (CoI), Lim, H. H. (CoI), Melton-Meaux, G. B. (CoI), Nunez, A. (CoI), Pakhomov, S. V. (CoI), Pieczkiewicz, D. S. (CoI), Randolph, A. C. (CoI), Riggs, S. (CoI), Rudser, K. (CoI), Schleiss, M. R. (CoI), Shen, S. (CoI), Vaughn, B. P. (CoI) & Vock, D. M. (CoI)
NIH NAT'L CTR FOR ADVANCING TRAN SCIENCE
9/18/23 → 7/31/30
Project: Research project
-
Genetic Epidemiology of COPD (COPD Gene)
Billings, J. L. (PI)
NATIONAL JEWISH HEALTH, NATIONAL INSTITUTES OF HEALTH (NIH)
8/10/23 → 8/9/25
Project: Research project
-
A Phase 1 Single Dose Escalation Study Evaluating the Safety and Tolerability ofVX-522 in Subjects 18 Years of Age and Older With Cystic Fibrosis and a CFTRGenotype Not Responsive to CFTR Modulator Therapy
Billings, J. L. (PI)
VERTEX PHARMACEUTICALS INCORPORATED
10/1/22 → 10/1/26
Project: Research project
-
Assessing Safety of Discontinuing Hypertonic Saline in Those with Lower Forced Expiratory Volume in 1 Second after Elexacaftor/Tezacaftor/Ivacaftor
Nichols, D., Gifford, A., Russell, R., Odem-Davis, K., Young, J., Amaro-Galvez, R., Billings, J., Mukadam, Z. & Mayer-Hamblett, N., Feb 1 2024, In: Annals of the American Thoracic Society. 21, 2, p. 360-362 3 p.Research output: Contribution to journal › Letter › peer-review
3 Scopus citations -
Attitudes toward and preparedness for lung transplantation among individuals with cystic fibrosis in the era of highly effective modulators
Burdis, N., Kapnadak, S. G., Bartlett, L. E., McElvaney, O., Milinic, T., Wai, T. H., Lange, A. V., Reid, N., Dunitz, J. M., Billings, J. L., Pilewski, J. M., Saavedra, M., Goss, C. H., Hartzler, A. L. & Ramos, K. J., Dec 2024, In: BMC Pulmonary Medicine. 24, 1, 348.Research output: Contribution to journal › Article › peer-review
Open Access -
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials
ACTT-4 Study Group, Mar 1 2024, In: EClinicalMedicine. 69, p. 102472 102472.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Proteomics and machine learning in the prediction and explanation of low pectoralis muscle area
OPDGene Study Consortium, Dec 2024, In: Scientific reports. 14, 1, 17981.Research output: Contribution to journal › Article › peer-review
Open Access -
SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir
Singh, K., Rubenstein, K., Callier, V., Shaw-Saliba, K., Rupert, A., Dewar, R., Laverdure, S., Highbarger, H., Lallemand, P., Huang, M. L., Jerome, K. R., Sampoleo, R., Mills, M. G., Greninger, A. L., Juneja, K., Porter, D., Benson, C. A., Dempsey, W., El Sahly, H. M. & Focht, C. & 187 others, , Sep 15 2024, In: Journal of Infectious Diseases. 230, 3, p. 624-634 11 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations